Healius Limited (ASX:HLS)
Australia
· Delayed Price · Currency is AUD 0.980
-0.005 (-0.51%)
At close: Dec 5, 2025
Healius Revenue
In the fiscal year ending June 30, 2025, Healius had annual revenue of 1.34B AUD with 5.69% growth.
Revenue
1.34B
Revenue Growth
-8.16%
P/S Ratio
0.53
Revenue / Employee
225.46K
Employees
8,224
Market Cap
711.61M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 1.34B | 72.40M | 5.69% |
| Jun 30, 2024 | 1.27B | -435.10M | -25.49% |
| Jun 30, 2023 | 1.71B | -582.00M | -25.43% |
| Jun 30, 2022 | 2.29B | 374.70M | 19.57% |
| Jun 30, 2021 | 1.91B | 344.40M | 21.94% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 23.73B |
| Pro Medicus | 212.98M |
| Cochlear | 2.34B |
| Sonic Healthcare | 9.65B |
| Ramsay Health Care | 17.79B |
| Ansell | 3.06B |
| Telix Pharmaceuticals | 1.01B |
| Mesoblast | 26.23M |